Rhythm Pharmaceuticals Announces New Topline Clinical Data from Ongoing Phase 2 Basket Studies Evaluating Setmelanotide in Rare Genetic Disorders of Obesity

Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering

bluebird bio Presents New Data from Northstar (HGB-204) and Northstar-2 (HGB-207) Studies of LentiGlobin™ Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia at Annual Congress of the European Hematology Association

bluebird bio Announces New Interim Data from Phase 1 (HGB-206) Study of LentiGlobinâ„¢ Gene Therapy in Patients with Severe Sickle Cell Disease at Annual Congress of the European Hematology Association

Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity